The use of aspirin in healthy elderly patients as a preventative strategy was associated with no prolongation of long-term disability-free survival compared with placebo.
Overall response of platelet count 50,000/L seen in 43% of patients.
Lower bleeding rate with administration once weekly, every 2 weeks vs no prophylaxis.
But in past 3 decades, decrease in late mortality seen among those who underwent BMT in childhood.
L-Glutamine oral treatment with or without hydroxyurea reduces pain crises better than placebo in individuals with sickle cell disease.
Platelet counts of 150,000/mm at time of delivery more common with pregnancy-related complications
Two devices designed to create arteriovenous fistula in patients with CKD in need of hemodialysis
More major bleeding seen at maximal activated clotting time greater than 290 seconds.
Single blood sample looking at fasting glucose and HbA1c was a key predictor of subsequent diagnosis of diabetes.
The Agency is urging manufacturers to stop marketing OTC oral drug products containing benzocaine for teething to this patient population.
Advances in new reversal agents will be key for managing patients treated with DOACs to prevent major bleeding events.
Benefits of protection with 2 doses administered over 1 month make the vaccine an important option for prevention of HBV.
With use of CD34+ cells via BB305 vector transduction, patients with severe β-thalassemia may no longer require long-term RBC transfusions as frequently or at all.
Increase in estimated population prevalence of elevated blood pressure from 11.8 to 14.2%.
In this meta-analysis of prospective population-based studies, sickle cell trait was not associated with any difference in risk of first ischemic stroke.
No moderate- or high-level evidence was found that SEP-1 or its hemodynamic interventions increase survival in septic adults.
A clinical prediction tool successfully forecasts subarachnoid hemorrhage management from ruptured intracranial aneurysms.
Increased frequency of television viewing may be linked to an increased risk for venous thromboembolism.
The addition of pharmacomechanical thrombolysis does not reduce the risk of post-thrombotic syndrome among patients with acute proximal deep vein thrombosis.
A 60-year-old man with a history of gastroesophageal reflux disease presents to the emergency department with 2 to 3 days of fever, non-bloody diarrhea, and a worsening non-pruritic rash.
New FDA-approved prophylactic treatment decreases bleeding episodes hemophilia A patients with factor VIII inhibitors.
An evaluation begins with a focused history and physical examination, CBC count with platelet trend, and examination of the peripheral smear.
Warfarin use may provide cancer protection across a broad range of malignant neoplasms.
In the 1 to 10 days after flu vaccine administration, there was no increased risk for VTE.
The researchers found that concurrent use of amiodarone, fluconazole, rifampin, and phenytoin was associated with increased risk of major bleeding compared with the use of NOACs alone.
VTE and cancer are the result of inflammation and immunological dysfunctions associated with RA.
A Divine guidance helps a nurse practitioner make a diagnosis that saved a patient's life.
A patient presents with chest pain 6 weeks after beginning use of a contraceptive device.
The updated guidelines will help clinicians prevent and manage nausea and vomiting caused by antineoplastic agents or radiation therapy in cancer patients.
Researchers found a paradoxical increase in thromboembolism risk in low-weight patients with atrial fibrillation and VTE who were treated with direct oral anticoagulants.